Teva Investigational Site 13821 — New Haven, Connecticut

Teva Investigational Site 13821 is a clinical research site located in New Haven, Connecticut, United States 06510-2483.

Crixeo Health Trust Score: 49/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 13821 has participated in 3 clinical trials.

Therapeutic areas: Cluster Headache, Episodic Cluster Headache, Chronic Cluster Headache.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 49/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 13821?

Teva Investigational Site 13821 has a Crixeo Trust Score of 49/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 13821 conducted?

Teva Investigational Site 13821 has 3 clinical trials on record. Their work covers Cluster Headache, Episodic Cluster Headache, Chronic Cluster Headache.

Is Teva Investigational Site 13821 accredited by Crixeo Health?

Teva Investigational Site 13821 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 13821?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.